Latest Foresite Capital Management V, LLC Stock Portfolio

About Foresite Capital Management V, LLC and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Foresite Capital Management V, LLC reported an equity portfolio of $108.7 Millions as of 30 Sep, 2025.

The top stock holdings of Foresite Capital Management V, LLC are , , . The fund has invested 37.2% of it's portfolio in CG ONCOLOGY, INC. and 21.2% of portfolio in ALUMIS INC.

They significantly reduced their stock positions in MAZE THERAPEUTICS, INC.. The fund showed a lot of confidence in some stocks as they added substantially to LYELL IMMUNOPHARMA, INC. (LYEL).

Foresite Capital Management V, LLC Annual Return Estimates Vs S&P 500

New Buys

No new stocks were added by Foresite Capital Management V, LLC

Additions

Ticker	% Inc.
lyell immunopharma, inc.	17.32

Additions to existing portfolio by Foresite Capital Management V, LLC

Reductions

Ticker	% Reduced
maze therapeutics, inc.	-75.00

Foresite Capital Management V, LLC reduced stake in above stock

Sold off

None of the stocks were completely sold off by Foresite Capital Management V, LLC

Sector Distribution

Sector	%
Others	78.6
Consumer Defensive	14.2
Healthcare	7.1

Market Cap. Distribution

Category	%
UNALLOCATED	78.6
MID-CAP	14.2
SMALL-CAP	7.1

Stocks belong to which Index?

Index	%
Others	78.6
RUSSELL 2000	21.4

Top 5 Winners (%)		%
LYEL	lyell immunopharma, inc.	73.0 %
	maze therapeutics, inc.	69.6 %
	cg oncology, inc.	54.9 %
	alumis inc.	33.0 %
	disc medicine, inc.	24.8 %

Top 5 Winners ($)		$
	cg oncology, inc.	14.3 M
	alumis inc.	5.7 M
	disc medicine, inc.	3.9 M
LYEL	lyell immunopharma, inc.	3.3 M
	maze therapeutics, inc.	2.9 M

Top 5 Losers (%)		%

Top 5 Losers ($)		$

Foresite Capital Management V, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Foresite Capital Management V, LLC

Last Reported on: 14 Nov, 2025

Ticker	Namesorted ascending	% Portfolio	Shares Held	$ Value	Type	% Change
HIMS	hims & hers health, inc.	14.25	273,151	15,493,100	unchanged	0.00

LYEL	lyell immunopharma, inc.	7.12	477,078	7,747,750	added	17.32

	cg oncology, inc.	37.19	1,004,050	40,443,100	unchanged	0.00

	alumis inc.	21.20	5,779,350	23,059,600	unchanged	0.00

	disc medicine, inc.	18.17	299,069	19,762,500	unchanged	0.00

	maze therapeutics, inc.	2.06	86,291	2,237,530	reduced	-75.00